Author:
Limouris Georgios S.,Krylov Valery,Dolgushin Michael B.,Zafeirakis Athanasios G.
Publisher
Springer International Publishing
Reference39 articles.
1. Rindi G, Klimstra DS, Abedi-Ardekani B, et al. A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. Mod Pathol. 2018;31(12):1770–86.
2. Hayashi T, Mete O. Head and neck paragangliomas: what does the pathologist need to know? Diagn Histopathol. 2014;20:316–25.
3. Saveanu A, Muresan M, de Micco C, et al. Expression of somatostatin receptors, dopamine D2 receptors, noradrenaline transporters, and vesicular monoamine transporters in 52 pheochromocytomas and paragangliomas. Endocr Relat Cancer. 2011;18:287–300.
4. Reubi JC, Waser B, Liu Q, Laissue JA, et al. Subcellular distribution of somatostatin sst2A receptors in human tumors of the nervous and neuroendocrine systems: membranous versus intracellular location. J Clin Endocrinol Metab. 2008;85:3882–91.
5. Binderup T, Knigge U, Mellon Mogensen A, et al. Quantitative gene expression of somatostatin receptors and noradrenaline transporter underlying scintigraphic results in patients with neuroendocrine tumors. Neuroendocrinology. 2008;87:223–32.